Cetera Investment Advisers
BLFS icon

Cetera Investment Advisers’s BioLife Solutions BLFS Stock Holding History

Cetera Investment Advisers’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259K Sell
9,187
-2,427
-21% -$56.7K ﹤0.01% 4278
2026
Q1 		$222K Buy
11,614
+2,458
+27% +$54.3K ﹤0.01% 4220
2025
Q4 		$221K Sell
9,156
-578
-6% -$15.1K ﹤0.01% 4169
2025
Q3 		$248K Buy
+9,734
New +$231K ﹤0.01% 3992
2025
Q2 		– Sell
-13,089
Closed -$299K – 4102
2025
Q1 		$299K Buy
+13,089
New +$345K ﹤0.01% 3271

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cetera Investment Advisers's BLFS Position: Q2 2026 in Review

Cetera Investment Advisers reduced its BioLife Solutions (BLFS) stake by 21% in Q2 2026, selling an estimated $56.7K and leaving 9,187 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #4278.

Cetera Investment Advisers first reported a position in BLFS in Q1 2025 and has held it in 5 quarters since. The position peaked at $299K in Q1 2025. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Cetera Investment Advisers held 9,187 shares of BioLife Solutions worth $259K as of Q2 2026.
  • Cetera Investment Advisers sold 2,427 BioLife Solutions shares in Q2 2026, an estimated $56.7K.
  • BioLife Solutions made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4278 holding.
  • Cetera Investment Advisers first reported a position in BioLife Solutions in Q1 2025 and has held it in 5 quarters since.
  • Cetera Investment Advisers's BioLife Solutions position peaked at $299K in Q1 2025.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.